Krilogy Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Krilogy Financial's JAZZ Position: Q3 2026 in Review
Krilogy Financial reduced its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q3 2026, selling an estimated $82.8K and leaving 1,729 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #766.
Krilogy Financial first reported a position in JAZZ in Q3 2015 and has held it in 14 quarters since. The position peaked at $541K in Q4 2015. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Krilogy Financial held 1,729 shares of Jazz Pharmaceuticals worth $375K as of Q3 2026.
- Krilogy Financial sold 335 Jazz Pharmaceuticals shares in Q3 2026, an estimated $82.8K.
- Jazz Pharmaceuticals made up 0.01% of Krilogy Financial's portfolio in Q3 2026, its #766 holding.
- Krilogy Financial first reported a position in Jazz Pharmaceuticals in Q3 2015 and has held it in 14 quarters since.
- Krilogy Financial's Jazz Pharmaceuticals position peaked at $541K in Q4 2015.
- 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.